Cargando…
Pharmacodynamic Biomarker Development for PI3K Pathway Therapeutics
The phosphatidylinositol 3-kinase (PI3K) signaling pathway is integral to many essential cell processes, including cell growth, differentiation, proliferation, motility, and metabolism. Somatic mutations and genetic amplifications that result in activation of the pathway are frequently detected in c...
Autores principales: | Josephs, Debra H., Sarker, Debashis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762492/ https://www.ncbi.nlm.nih.gov/pubmed/26917948 http://dx.doi.org/10.4137/TOG.S30529 |
Ejemplares similares
-
Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?
por: Thillai, Kiruthikah, et al.
Publicado: (2016) -
The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
por: Cheaib, Bianca, et al.
Publicado: (2015) -
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
por: Barzegar Behrooz, Amir, et al.
Publicado: (2022) -
Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval
por: Strauss, David G., et al.
Publicado: (2022) -
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2013)